
Optomed USA has announced the launch of Optomed Lumo, a handheld, non-mydriatic fundus camera designed to bring high-quality retinal imaging to a wide range of clinical settings, including primary care, community clinics, and remote healthcare environments. The device is now available in the United States and was introduced in response to increasing demand for accessible ocular diagnostics beyond traditional ophthalmology and optometry practices.
The Optomed Lumo is a non-mydriatic fundus camera, cleared by the FDA under the PJZ product code, and is intended to capture and store ocular images for clinical evaluation. The device supports wireless DICOM (Digital Imaging and Communications in Medicine) integration, programmable workflows, and intuitive user guidance, enhancing usability across diverse clinical environments.
David Frasch, Managing Director of Optomed USA, emphasized the accessibility goals behind the product:
“Optomed Lumo represents a major step toward our mission of making retinal imaging more accessible. By combining mobility, usability, and seamless integration, we’re helping clinicians to bring eye imaging to patients wherever they are—whether in a clinic, community center, or remote care setting.”
The launch aims to address the growing recognition of the retina as a key indicator of systemic health. By equipping primary care providers and mobile healthcare programs with tools like the Optomed Lumo, clinicians can detect and monitor ocular and systemic conditions even in underserved areas.
According to Laura Piila, Vice President of Devices at Optomed, the Lumo was developed in close collaboration with healthcare professionals to ensure it aligns with practical, real-world demands:
“Its intuitive interface, dual form factor, and connectivity features make it easy to adopt. Optomed Lumo’s versatility as both a handheld and desktop device makes it an ideal fit for any care environment.”